Push the boundaries of healthcare data.
Evolve the way you access, manage and apply patient-centric insights.
Welcome to the prognosFACTOR Marketplace
The #1 source of purpose-built lab data, now with an entire ecosystem of healthcare data assets at your fingertips.
-
Access with unlimited queries (counts) of the Prognos Marketplace.
Understand your market opportunity in minutes with access to fully integrated lab data, open and closed medical claims, as well as Rx claims from the most trusted sources. Lab data includes commercial and academic, specialty oncology & testing sources.
-
Manage your data securely in the cloud.
Our advanced platform and common tokenization engine make it easy and seamless. Leverage our marketplace data and/or bring your own data. 5+ years of history from the largest open and closed claim sources covering medical, institutional, and pharmacy claims, as well as commercial Medicare Advantage & Medicaid, and updated weekly.
-
Apply your insights rapidly and course correct with ease.
Prognos offers a suite of patient centric software applications that address HEOR, RWE, and Commercial needs from cohort design to patient journey insights to omnichannel marketing to segmenting key providers. Prove the ROI of your marketing efforts.
Discover a Better Way to Buy Patient Data
Digital marketplaces have made accessing and obtaining desired goods and services considerably faster and more convenient for both B2C and B2B buyers. Isn’t it time this same digital-first approach was applied to the way life science companies like yours search, access, evaluate, and purchase the real-world patient data necessary to drive clinical and commercialization efforts?
The indispensability of RWD to the future of pharma
Last month, new bipartisan legislation was introduced to harness real-world evidence gathered during emergency use authorization to support future approvals of drugs, biologics, and medical devices by the FDA. Real world data proves value, but challenges remain. Learn how to successfully navigate the RWD landscape and accelerate the process of bringing a new brand to market.
Lowering the Stakes of Real World Data Purchases
The process of data selection and purchasing for anonymous patient longitudinal data (APLD) is rife with inefficiencies and challenges. We regularly hear from pharmaceutical customers about the frustration of managing multiple data vendors to acquire broad and diverse healthcare data to drive commercial, RWE, outcomes, and clinically-focused analytics. The standard way of acquiring this data is a time consuming and costly aspect of doing business. We knew there had to be a better way.
Evolve the Way You Access, Manage, and
Apply Patient-Centric Insights
Access an entire ecosystem of healthcare data assets you need
to answer even your most complex questions.